Boutique histopathology company

Patient care & research

I established and ran (for 6 years) a priority-driven, transparent research grant program

Small but smart Swedish biotech company with a range of diagnostics, including a low-cost, high-tech HIV viral load assay, ExaVir Load v3.

Also member of the Audit Committee

I was the Managing Director of the ASX-listed biotech company Narhex Life Sciences from mid-2005 to late 2007; prior to that I had been a non-executive director since 2001. The company was developing an HIV protease inhibitor; my salient contributions were to (1) regularize the drug dossier, (2) develop, organize and conduct a pivotal phase 1b clinical trial showing that this investigational PI was acid labile and needed coating to protect it from gastric acid, and that blood levels of the… Show more I was the Managing Director of the ASX-listed biotech company Narhex Life Sciences from mid-2005 to late 2007; prior to that I had been a non-executive director since 2001. The company was developing an HIV protease inhibitor; my salient contributions were to (1) regularize the drug dossier, (2) develop, organize and conduct a pivotal phase 1b clinical trial showing that this investigational PI was acid labile and needed coating to protect it from gastric acid, and that blood levels of the drug were dramatically increased by "boosting" with the drug ritonavir. Show less

I was a member of the audit committee and Chair of the Board Review committee. I was also Chairman for ~6 years in early 2000.